"Best Multi-Specialty Hospital in India, Shalby Hospitals providing Advanced Healthcare Services including Knee Replacement Surgery, Hip Joint Replacement, Cardiology, Oncology, Neurosurgery, Dental, Nephrology, Liver Transplant, Cosmetic surgery, and many more Health Care Services with Network of 11 Hospitals in India. Book Your Appointment Today."

During the past decade, Shalby Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shalby Hospital" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Asahi Kasei Pharma America Corporation" with 1 trials sponsored and "Biocad" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shalby Hospital" #1 collaborator was "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Shalby Hospital" are "Rheumatoid Arthritis" (5 trials), "Arthritis, Rheumatoid" (2 trials), "Chronic Kidney Disease Stage 5 on Dialysis" (1 trials), "Coagulopathy" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Shalby Hospital" in a lesser frequency.

Most popular intervention types in "Shalby Hospital" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "Placebo" (2 trials), "ART-123" (1 trials), "Adalimumab" (1 trials) and "BCD-055" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shalby Hospital" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Shalby Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Shalby Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shalby Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".